Nayzilam
Payments companies reported to CMS as associated with Nayzilam. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Nayzilam, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Nayzilam
These are the largest totals companies reported as associated with Nayzilam. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| David Burdette | Grand Rapids, MI | Epilepsy | $99,709.69 |
| Laurence Petty | Plant City, FL | Hospice and Palliative Medicine (Internal Medicine) | $60,533.23 |
| Atiya Khan | Fort Wayne, IN | Neurology With Special Qualifications In Child Neurology | $58,573.16 |
| Tricia Ting | Washington, DC | Neurology (Psychiatry & Neurology) | $48,024.87 |
| John Stern | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $41,865.56 |
| Tariq Gheith | East Lansing, MI | Neurology (Psychiatry & Neurology) | $41,573.16 |
| Mounzer Yassin Kassab | East Lansing, MI | Vascular Neurology | $38,012.37 |
| David King Stephens | Orange, CA | Epilepsy | $34,448.79 |
| Steve Chung | Phoenix, AZ | Neurology (Psychiatry & Neurology) | $33,856.33 |
| Jesus Pina Garza | Nashville, TN | Neurology With Special Qualifications In Child Neurology | $33,600.44 |
Prescribed Nayzilam?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.